Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
Phase 3 Unknown
276 enrolled
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
Phase NA Unknown
120 enrolled
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 1/2 Unknown
37 enrolled
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Phase 1 Unknown
12 enrolled
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 2 Unknown
17 enrolled
SU006668 in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
Phase 2 Unknown
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
Phase 1/2 Unknown
64 enrolled
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2 Unknown
Brachytherapy in Treating Patients With Recurrent Prostate Cancer
Phase 1/2 Unknown
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Phase 2 Unknown
18 enrolled
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 1 Unknown
Lycopene in Preventing Prostate Cancer in Healthy Participants
Phase NA Unknown
150 enrolled
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
Phase 2 Unknown
800 enrolled
Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners
Phase NA Unknown
100 enrolled
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
Phase 3 Unknown
900 enrolled
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Phase 3 Unknown
396 enrolled
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Phase NA Unknown
2,200 enrolled
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
2,000 enrolled
Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer
Phase 1 Unknown
198 enrolled
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
Unknown
21,000 enrolled
High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer
Phase 2 Unknown
26 enrolled
High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer
Phase 2 Unknown
26 enrolled
Study of Treatment Choice in Patients With Localized Prostate Cancer
Phase NA Unknown
432 enrolled
Dutasteride in Treating Patients With Prostate Cancer
Phase 2 Unknown
42 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
Phase 3 Unknown
200 enrolled
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
Unknown
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 1 Unknown
Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
Phase 3 Unknown
2,000 enrolled
MRI in Diagnosing Prostate Cancer
Phase NA Unknown
714 enrolled
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
Phase 3 Unknown
75 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2 Unknown
DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
Phase 2 Unknown
A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA
Phase 1 Unknown